CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-22 | Zaks Tal Zvi Director | Grant or award · Option to purchase Ordinary Shares | +124,000 | 124,000 | ||
| 2018-06-22 | Kerr Giles Francis Bertram Director | Grant or award · Option to purchase Ordinary Shares | +124,000 | 124,000 | ||
| 2018-06-22 | Sigal Charles Elliott Director | Grant or award · Option to purchase Ordinary Shares | +154,809 | 154,809 | ||
| 2018-06-22 | Duncan Barbara Gayle Director | Grant or award · Option to purchase Ordinary Shares | +158,233 | 158,233 | ||
| 2018-06-06 | Thompson Peter A. Director | Sale | −1,600 | $13.49 | $22K | 4,901,310 |
| 2018-06-06 | ORBIMED ADVISORS LLC Director | Sale | −1,600 | $13.49 | $22K | 4,901,310 |
| 2018-06-04 | Thompson Peter A. Director | Sale | −17,100 | $13.57 | $232K | 4,902,910 |
| 2018-06-04 | ORBIMED ADVISORS LLC Director | Sale | −17,100 | $13.57 | $232K | 4,902,910 |
| 2018-06-01 | Thompson Peter A. Director | Sale | −50,000 | $13.49 | $675K | 4,920,010 |
| 2018-06-01 | ORBIMED ADVISORS LLC Director | Sale | −50,000 | $13.49 | $675K | 4,920,010 |
| 2018-05-30 | Thompson Peter A. Director | Sale | −121,000 | $13.52 | $1.6M | 4,970,010 |
| 2018-05-30 | ORBIMED ADVISORS LLC Director | Sale | −121,000 | $13.52 | $1.6M | 4,970,010 |
| 2018-05-14 | Thompson Peter A. Director | Sale | −10,300 | $13.50 | $139K | 5,091,010 |
| 2018-05-14 | ORBIMED ADVISORS LLC Director | Sale | −10,300 | $13.50 | $139K | 5,091,010 |
| 2018-03-29 | Thompson Peter A. Director | Sale | −31,983 | $11.53 | $369K | 5,101,310 |
| 2018-03-29 | ORBIMED ADVISORS LLC Director | Sale | −31,983 | $11.53 | $369K | 5,101,310 |
| 2018-03-27 | Thompson Peter A. Director | Sale | −1,016,084 | $11.50 | $11.7M | 5,133,293 |
| 2018-03-27 | ORBIMED ADVISORS LLC Director | Sale | −1,016,084 | $11.50 | $11.7M | 5,133,293 |
| 2018-03-27 | Viswanathan Ravi 10% owner | Purchase | +6,000,000 | $1.92 | $11.5M | 79,978,672 |
| 2018-03-27 | Sonsini Peter W. 10% owner | Purchase | +6,000,000 | $1.92 | $11.5M | 79,978,672 |
Page 18 of 23 · 454 trades